← Eichor
Study identifier: NCT02255331 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity

Condition: Complications; Arthroplasty · Complications; Arthroplasty, Mechanical  ·  Sponsor: Hospital for Special Surgery, New York

PhaseN/A
Planned participants240
Who can joinAll sexes, 21 Years to 95 Years
Healthy volunteersNo

About this study

Patients with a total hip replacement may require early revision surgery due to an adverse local tissue reaction or bone resorption that occurs due to wear debris released from the implant. MRI provides a non-invasive biomarker for clinicians and surgeons to detect early adverse synovial reactions which may exist in the absence of clinical symptoms, thus imparting essential information for clinical management. This study will address two of the most commons causes of hip implant failure, including adverse local tissue reaction in implants not traditionally associated with adverse tissue reactions, as well as the presence of aseptic loosening and loss of implant-bone integration.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew F Koff, PhD  ·  212-774-2103  ·  koffm@hss.edu

Mauro Miranda, MFA  ·  212-774-1979  ·  mirandam@hss.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital for Special SurgeryNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02255331